Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion
for
Degenerative Spondylolisthesis
Location: Los Angeles CA, Rochester MN, Columbus OH
Sponsor: Ankasa Regenerative Therapeutics, Inc.
Sex: All
Age: 50+
Code: NCT04378543
Phase 1, Phase 2, Recruiting
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Los Angeles CA, Orange CA, Las Vegas NV, Scottsdale AZ,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06290141
Phase 3, Recruiting
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
for
Colorectal Cancer Metastatic
Location: Los Angeles CA, Newport Beach CA
Sponsor: Buzzard Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06634875
Phase 2, Recruiting
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for
Major Depressive Disorder
Location: Los Angeles CA, Irvine CA, Walnut Creek CA, Orem UT,
Sponsor: Syndeio Biosciences, Inc
Sex: All
Age: 18 - 64
Code: NCT06547489
Phase 2, Recruiting
Featured
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: Los Angeles CA, Clovis CA, Tucson AZ, Eugene OR,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase 3, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants
for
Healthy Volunteer
Location: Anaheim CA, Grayslake IL
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07736638
Phase 1, Recruiting
FeaturedActive & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Sherman Oaks CA, Long Beach CA, Anaheim CA, Temecula CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase 2, Recruiting
Aneurysm Genetic Risk in Patients With QIB Changes
for
Brain Aneurysm
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT05317169
Recruiting
FeaturedActive & Responsive
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
for
Bipolar I Disorder, Bipolar II Disorder
Location: Sherman Oaks CA, Montclair CA, Anaheim CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06696755
Phase 2, Recruiting
FeaturedActive & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Los Angeles CA, Long Beach CA, Anaheim CA, Colton CA,